Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs AJANTA PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN AJANTA PHARMA LUPIN/
AJANTA PHARMA
 
P/E (TTM) x 40.7 37.9 107.3% View Chart
P/BV x 6.0 8.2 72.6% View Chart
Dividend Yield % 0.2 0.3 78.3%  

Financials

 LUPIN   AJANTA PHARMA
EQUITY SHARE DATA
    LUPIN
Mar-23
AJANTA PHARMA
Mar-23
LUPIN/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs7991,426 56.0%   
Low Rs5831,062 54.9%   
Sales per share (Unadj.) Rs365.8297.2 123.1%  
Earnings per share (Unadj.) Rs9.846.7 21.1%  
Cash flow per share (Unadj.) Rs29.257.1 51.1%  
Dividends per share (Unadj.) Rs4.007.00 57.1%  
Avg Dividend yield %0.60.6 102.9%  
Book value per share (Unadj.) Rs270.7269.1 100.6%  
Shares outstanding (eoy) m454.98125.91 361.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.94.2 45.1%   
Avg P/E ratio x70.226.6 263.6%  
P/CF ratio (eoy) x23.721.8 108.6%  
Price / Book Value ratio x2.64.6 55.2%  
Dividend payout %40.715.0 271.2%   
Avg Mkt Cap Rs m314,381156,638 200.7%   
No. of employees `000NANA-   
Total wages/salary Rs m30,8727,851 393.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m166,41737,426 444.7%  
Other income Rs m1,509986 153.0%   
Total revenues Rs m167,92638,413 437.2%   
Gross profit Rs m17,2067,833 219.7%  
Depreciation Rs m8,8071,308 673.3%   
Interest Rs m2,74358 4,696.9%   
Profit before tax Rs m7,1657,453 96.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,6881,573 170.9%   
Profit after tax Rs m4,4775,880 76.1%  
Gross profit margin %10.320.9 49.4%  
Effective tax rate %37.521.1 177.8%   
Net profit margin %2.715.7 17.1%  
BALANCE SHEET DATA
Current assets Rs m124,51328,252 440.7%   
Current liabilities Rs m92,65411,393 813.3%   
Net working cap to sales %19.145.0 42.5%  
Current ratio x1.32.5 54.2%  
Inventory Days Days2666 39.8%  
Debtors Days Days9810 953.4%  
Net fixed assets Rs m103,49018,707 553.2%   
Share capital Rs m910253 360.1%   
"Free" reserves Rs m122,24633,624 363.6%   
Net worth Rs m123,15633,877 363.5%   
Long term debt Rs m27513 2,200.8%   
Total assets Rs m228,00347,047 484.6%  
Interest coverage x3.6128.6 2.8%   
Debt to equity ratio x00 605.4%  
Sales to assets ratio x0.70.8 91.7%   
Return on assets %3.212.6 25.1%  
Return on equity %3.617.4 20.9%  
Return on capital %8.022.2 36.2%  
Exports to sales %059.9 0.0%   
Imports to sales %011.5 0.0%   
Exports (fob) Rs mNA22,420 0.0%   
Imports (cif) Rs mNA4,293 0.0%   
Fx inflow Rs m48,05722,420 214.3%   
Fx outflow Rs m21,7524,293 506.7%   
Net fx Rs m26,30618,127 145.1%   
CASH FLOW
From Operations Rs m18,9727,918 239.6%  
From Investments Rs m-12,868-5,596 229.9%  
From Financial Activity Rs m-3,373-1,079 312.6%  
Net Cashflow Rs m2,7321,243 219.8%  

Share Holding

Indian Promoters % 46.8 66.2 70.6%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 45.8 25.8 177.8%  
FIIs % 16.1 9.1 176.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 53.0 33.8 156.7%  
Shareholders   281,542 54,351 518.0%  
Pledged promoter(s) holding % 0.0 12.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Lupin vs AJANTA PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Lupin vs AJANTA PHARMA Share Price Performance

Period Lupin AJANTA PHARMA S&P BSE HEALTHCARE
1-Day 1.12% 1.47% 1.33%
1-Month 0.05% 6.50% -0.61%
1-Year 150.87% 90.95% 62.05%
3-Year CAGR 17.09% 21.22% 18.22%
5-Year CAGR 17.40% 26.59% 19.82%

* Compound Annual Growth Rate

Here are more details on the Lupin share price and the AJANTA PHARMA share price.

Moving on to shareholding structures...

The promoters of Lupin hold a 47.0% stake in the company. In case of AJANTA PHARMA the stake stands at 66.2%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Lupin and the shareholding pattern of AJANTA PHARMA.

Finally, a word on dividends...

In the most recent financial year, Lupin paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 40.7%.

AJANTA PHARMA paid Rs 7.0, and its dividend payout ratio stood at 15.0%.

You may visit here to review the dividend history of Lupin, and the dividend history of AJANTA PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.